+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis



Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis



Bulletin of the World Health Organization 62(5): 763-771



An investigation of 142 patients with primary destructive pulmonary tuberculosis was carried out using several immunological tests to estimate the quantitative and functional status of the T- and B-lymphocyte systems and the specific cell-mediated and humoral immunity. It was shown that the status of the immune system, and that of the specific antituberculosis immunity in particular, were dependent on the severity of the tuberculosis process. There were indications that the immune status largely determined the extent of the infiltrative lesions, as well as the course of the disease. In patients with no pronounced defects in cell-mediated immunity in general and in specific immunity in particular, the time needed for sputum samples to become bacterially negative and for the cavities to close was reduced, especially in cases where the initial bacterial excretion was not heavy and the degree of the infiltration was not severe. Defects in the immune system impeded the clinical progress of the tuberculosis patients; moreover, complete clinical recovery in such cases was delayed and there was a higher incidence of reactivation of the disease during the main chemotherapy course as well as of recurrence of the disease at a later date.

(PDF emailed within 1 workday: $29.90)

Accession: 001580084

Download citation: RISBibTeXText

PMID: 6391716



Related references

Clinico-immunological criteria of the effectiveness of chemotherapy in patients with destructive pulmonary tuberculosis. Problemy Tuberkuleza: 42-45, 1986

Efficacy of chemotherapy of primary destructive pulmonary tuberculosis. Vrachebnoe Delo: 19-22, 1983

Immunological indices of patients with destructive pulmonary tuberculosis due to bovine and human Mycobacterium tuberculosis. Problemy Tuberkuleza: 34-36, 1987

L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis. Problemy Tuberkuleza: 38-43, 1983

Viability of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis. Problemy Tuberkuleza: 59-64, 1983

Clinico immunological criteria of chemotherapy efficacy in patients with destructive tuberculosis of the lungs. Problemy Tuberkuleza (2): 42-45, 1986

Immunological status of newly detected patients with destructive pulmonary tuberculosis. Problemy Tuberkuleza: 13-17, 1979

Chemotherapy of patients aged 50 and over with chronic destructive pulmonary tuberculosis. Vrachebnoe Delo 1: 75-79, 1972

Intravenous chemotherapy of patients with destructive forms of pulmonary tuberculosis. Problemy Tuberkuleza 49(8): 87-88, 1971

Efficacy of chemotherapy in patients with chronic destructive pulmonary tuberculosis. Vrachebnoe Delo (11): 41-42, 1989

The efficacy of using immunomodulators and chemotherapy in patients with destructive pulmonary tuberculosis. Azerbaidzhanskii Meditsinskii Zhurnal (9): 3-6, 1987

The efficacy of the chemotherapy of patients with chronic destructive pulmonary tuberculosis. Vrachebnoe Delo: 41-42, 1989

Results of intravenous chemotherapy in destructive pulmonary tuberculosis patients. Vrachebnoe Delo: 74-77, 1981

Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis. Problemy Tuberkuleza i Boleznei Legkikh: 37-39, 2009

Immunological characteristics of the side-effects of antibacterial preparations in pulmonary tuberculosis patients. Vrachebnoe Delo: 25-26, 1986